BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5110801)

  • 1. [Hepato-lenticular degeneration. Pathogenetic and genetic considerations].
    Cîmpeanu E; Tăranu A; Morariu M; Weiss G
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(3):583-90. PubMed ID: 5110801
    [No Abstract]   [Full Text] [Related]  

  • 2. [On hepato-lenticular degeneration (Wilson's disease). I. Detection and early diagnosis].
    Campanella G; Gillardi U; Germinario L
    Acta Neurol (Napoli); 1971; 26(4):403-22. PubMed ID: 5132823
    [No Abstract]   [Full Text] [Related]  

  • 3. Wilson's disease, presenting as chronic active hepatitis.
    Scott J; Gollan JL; Samourian S; Sherlock S
    Gastroenterology; 1978 Apr; 74(4):645-51. PubMed ID: 75819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aldolase, ceruloplasmin and copper levels in serum following surgery].
    Hankiewicz J; Rudzki P; Szeruda-Rudzka E
    Pol Przegl Chir; 1977; 49(1):9-18. PubMed ID: 834674
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract]   [Full Text] [Related]  

  • 6. [Wilson's disease. I].
    Sánchez Rodríquez A; González Macias J; Diez Jarilla JL; Suquia Múgica B; de Portugal Alvarez J
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):68-73. PubMed ID: 6753060
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Wilson's disease in asymptomatic patients.
    Sternlieb I; Scheinberg IH
    N Engl J Med; 1968 Feb; 278(7):352-9. PubMed ID: 5635646
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activity of aldolase, aminotransferases, phosphohexoisomerase and ceruloplasmin in the course of delirium tremens].
    Bukowczyk A; Radzikowska J
    Psychiatr Pol; 1969; 3(3):249-60. PubMed ID: 5805104
    [No Abstract]   [Full Text] [Related]  

  • 9. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 10. [Wilson's disease (hepatocerebral degeneration)].
    Sternlieb I
    Internist (Berl); 1976 Jul; 17(7):342-7. PubMed ID: 780309
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceruloplasmin: methods and clinical use.
    Wolf PL
    Crit Rev Clin Lab Sci; 1982; 17(3):229-45. PubMed ID: 6751692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of asymptomatic forms of hepatolenticular degeneration].
    Kuncová Z; Dittrich J; Nevsímalová S; Marecek Z; Heyrovský A
    Cesk Pediatr; 1971 Apr; 26(4):166-9. PubMed ID: 5553356
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzyme activity of the liver in patients with chronic diseases of the biliary tract and liver].
    Borevskaia BD; Gubergrits EA
    Vrach Delo; 1968 May; 5():24-6. PubMed ID: 5740449
    [No Abstract]   [Full Text] [Related]  

  • 14. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of aldolase, aminotransferases, phosphohexoisomerase and ceruloplasmin in the course of delirium tremens.
    Bukowczyk A; Radzikowska J
    Pol Med J; 1971; 10(1):227-38. PubMed ID: 5573906
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepato-lenticular degeneration in Vietnam. A statistical, clinical, developmental study on 10-year period concerning 8 personal cases].
    Bui Quoc Huong ; Nhut Thong N; Ngoc Quang N
    Presse Med (1893); 1970 May; 78(25):1147-50. PubMed ID: 5446208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic and therapeutic experiences in Wilson's disease. I. Pathogenesis, biochemistry and clinical aspects of Wilson's disease].
    Eichner B; Biesold D; Günther K; Lössner J; Bachmann H; Diessner H
    Folia Clin Int (Barc); 1974 Oct; 24(10):696-707. PubMed ID: 4430389
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening asymptomatic family members for Wilson's disease.
    Lindahl JA; Sharp HL
    Minn Med; 1982 Aug; 65(8):473-5. PubMed ID: 6752690
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepato-cerebral diseases and copper distribution in the tissues].
    Oyake Y; Kanbayashi K; Shirakawa K; Matsukawa K; Ogawa H
    Shinkei Kenkyu No Shimpo; 1969 Jun; 13(2):232-40. PubMed ID: 5390669
    [No Abstract]   [Full Text] [Related]  

  • 20. [Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
    Schmid-Rüter E; Feist D; Wesch H; Rossner JA; Schärer K
    Dtsch Med Wochenschr; 1973 Sep; 98(37):1698-703. PubMed ID: 4125854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.